RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Harbin Pharmaceutical Group Co Stock

Harbin Pharmaceutical Group Co Revenue 2024

Harbin Pharmaceutical Group Co Revenue

16.62 B CNY

Ticker

600664.SS

ISIN

CNE0000009T3

In 2024, Harbin Pharmaceutical Group Co's sales reached 16.62 B CNY, a 7.54% difference from the 15.46 B CNY sales recorded in the previous year.

The Harbin Pharmaceutical Group Co Revenue history

YEARREVENUE (undefined CNY)GROSS MARGIN (%)
2026e19.9820,13
2025e18.122,22
2024e16.6224,20
202315.4626,02
202213.8124,41
202112.823,31
202010.7920,91
201911.8323,72
201810.8126,78
201712.0225,89
201614.1326,20
201515.8624,42
201416.5127,03
201318.0929,27
201217.6631,72
201117.4629,21
201012.5429,24
200910.6831,34
20089.731,40
20078.2932,24
20069.2733,90
20058.4935,89
20047.1836,63

Harbin Pharmaceutical Group Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Harbin Pharmaceutical Group Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Harbin Pharmaceutical Group Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Harbin Pharmaceutical Group Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Harbin Pharmaceutical Group Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Harbin Pharmaceutical Group Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Harbin Pharmaceutical Group Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Harbin Pharmaceutical Group Co’s growth potential.

Harbin Pharmaceutical Group Co Revenue, EBIT and net profit per share

DateHarbin Pharmaceutical Group Co RevenueHarbin Pharmaceutical Group Co EBITHarbin Pharmaceutical Group Co Net Income
2026e19.98 B undefined0 undefined915.73 M undefined
2025e18.1 B undefined0 undefined686.8 M undefined
2024e16.62 B undefined0 undefined534.18 M undefined
202315.46 B undefined683.68 M undefined395.26 M undefined
202213.81 B undefined600.14 M undefined464.36 M undefined
202112.8 B undefined520.13 M undefined371.08 M undefined
202010.79 B undefined-875 M undefined-1.08 B undefined
201911.83 B undefined188 M undefined56 M undefined
201810.81 B undefined512 M undefined346 M undefined
201712.02 B undefined545 M undefined407 M undefined
201614.13 B undefined937 M undefined788 M undefined
201515.86 B undefined738 M undefined580 M undefined
201416.51 B undefined344 M undefined247 M undefined
201318.09 B undefined257 M undefined169 M undefined
201217.66 B undefined892 M undefined500 M undefined
201117.46 B undefined1.1 B undefined889 M undefined
201012.54 B undefined1.17 B undefined1.13 B undefined
200910.68 B undefined1.01 B undefined933 M undefined
20089.7 B undefined914 M undefined862 M undefined
20078.29 B undefined569 M undefined592 M undefined
20069.27 B undefined734 M undefined467 M undefined
20058.49 B undefined765 M undefined456 M undefined
20047.18 B undefined383 M undefined263 M undefined

Harbin Pharmaceutical Group Co stock margins

The Harbin Pharmaceutical Group Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Harbin Pharmaceutical Group Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Harbin Pharmaceutical Group Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Harbin Pharmaceutical Group Co's sales revenue. A higher gross margin percentage indicates that the Harbin Pharmaceutical Group Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Harbin Pharmaceutical Group Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Harbin Pharmaceutical Group Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Harbin Pharmaceutical Group Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Harbin Pharmaceutical Group Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Harbin Pharmaceutical Group Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Harbin Pharmaceutical Group Co Margin History

Harbin Pharmaceutical Group Co Gross marginHarbin Pharmaceutical Group Co Profit marginHarbin Pharmaceutical Group Co EBIT marginHarbin Pharmaceutical Group Co Profit margin
2026e26.02 %0 %4.58 %
2025e26.02 %0 %3.79 %
2024e26.02 %0 %3.21 %
202326.02 %4.42 %2.56 %
202224.41 %4.35 %3.36 %
202123.31 %4.06 %2.9 %
202020.91 %-8.11 %-9.99 %
201923.72 %1.59 %0.47 %
201826.78 %4.73 %3.2 %
201725.89 %4.53 %3.39 %
201626.2 %6.63 %5.58 %
201524.42 %4.65 %3.66 %
201427.03 %2.08 %1.5 %
201329.27 %1.42 %0.93 %
201231.72 %5.05 %2.83 %
201129.21 %6.32 %5.09 %
201029.24 %9.33 %9.01 %
200931.34 %9.45 %8.74 %
200831.4 %9.43 %8.89 %
200732.24 %6.86 %7.14 %
200633.9 %7.92 %5.04 %
200535.89 %9.01 %5.37 %
200436.63 %5.34 %3.67 %

Harbin Pharmaceutical Group Co Aktienanalyse

What does Harbin Pharmaceutical Group Co do?

Harbin Pharmaceutical Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Harbin Pharmaceutical Group Co's Sales Figures

The sales figures of Harbin Pharmaceutical Group Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Harbin Pharmaceutical Group Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Harbin Pharmaceutical Group Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Harbin Pharmaceutical Group Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Harbin Pharmaceutical Group Co stock

How much revenue did Harbin Pharmaceutical Group Co generate this year?

Harbin Pharmaceutical Group Co has achieved a revenue of 16.62 B CNY this year.

How much was the turnover of the company Harbin Pharmaceutical Group Co compared to the previous year?

The revenue of Harbin Pharmaceutical Group Co has increased by 7.54% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Harbin Pharmaceutical Group Co?

The revenue of Harbin Pharmaceutical Group Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Harbin Pharmaceutical Group Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Harbin Pharmaceutical Group Co so important for investors?

The revenue of Harbin Pharmaceutical Group Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Harbin Pharmaceutical Group Co pay?

Over the past 12 months, Harbin Pharmaceutical Group Co paid a dividend of 0.5 CNY . This corresponds to a dividend yield of about 16.13 %. For the coming 12 months, Harbin Pharmaceutical Group Co is expected to pay a dividend of 0 CNY.

What is the dividend yield of Harbin Pharmaceutical Group Co?

The current dividend yield of Harbin Pharmaceutical Group Co is 16.13 %.

When does Harbin Pharmaceutical Group Co pay dividends?

Harbin Pharmaceutical Group Co pays a quarterly dividend. This is distributed in the months of September, December, May, June.

How secure is the dividend of Harbin Pharmaceutical Group Co?

Harbin Pharmaceutical Group Co paid dividends every year for the past 3 years.

What is the dividend of Harbin Pharmaceutical Group Co?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Harbin Pharmaceutical Group Co located?

Harbin Pharmaceutical Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Harbin Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Harbin Pharmaceutical Group Co from 5/4/2018 amounting to 0.5 CNY, you needed to have the stock in your portfolio before the ex-date on 5/4/2018.

When did Harbin Pharmaceutical Group Co pay the last dividend?

The last dividend was paid out on 5/4/2018.

What was the dividend of Harbin Pharmaceutical Group Co in the year 2023?

In the year 2023, Harbin Pharmaceutical Group Co distributed 0 CNY as dividends.

In which currency does Harbin Pharmaceutical Group Co pay out the dividend?

The dividends of Harbin Pharmaceutical Group Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Harbin Pharmaceutical Group Co

Our stock analysis for Harbin Pharmaceutical Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Harbin Pharmaceutical Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.